患者报告的困扰可辅助特发性肺纤维化的临床决策:PROFILE队列分析
该研究基于英国特发性肺纤维化(IPF)临床队列,采用Rasch方法从45项姑息评估问卷中提取11项简版模型计算疾病困扰值,并与肺功能及12个月疾病进展或死亡进行关联分析,发现困扰评分可区分疾病进展与死亡,评分每增加1分12个月死亡风险增加10%。
要点
- 疾病困扰值与肺功能负相关(r=-0.275,对应DLCO占预计值百分比)。
- 实际问卷评分预测疾病进展和死亡的AUC分别为0.60和0.64。
- 评分每增加1分,12个月死亡风险增加10%;评分>18者近43%在105天内死亡。
核心结论
- 简版问卷可量化IPF患者的疾病困扰并预测预后,辅助临床决策。
研究设计与样本
- 英国临床队列的横断面研究,纳入新发IPF病例,采用基于Rasch方法的11项简版问卷计算疾病困扰值。
主要发现
- 疾病困扰值与DLCO占预计值百分比负相关(r=-0.275)。
- 由困扰值计算的预期问卷评分可区分疾病进展(n=8.8,p=0.004)和死亡(n=10.2,p=0.002)与无进展(n=6.9)。
- 实际问卷评分预测疾病进展和死亡的AUC分别为0.60和0.64。
- 实际评分每增加1分,12个月死亡风险增加10%;评分>18者中近43%在105天内死亡。
临床怎么用
- 可将简版困扰问卷用于IPF患者预后评估,辅助识别高死亡风险者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Idiopathic pulmonary fibrosis is a progressive and fatal interstitial lung disease. We aimed to determine if patient response to a palliative assessment survey could predict disease progression or death.We undertook a cross-sectional study in a UK clinical cohort of incident cases. Rasch-based methodology provided a disease distress value from an abridged 11-item model of the original 45-item survey. Distress values were compared with measures of lung function. Disease progression or mortality alone was predicted at 12 months from survey completion, with risk of death assessed at 3, 6 and 12 months.Disease distress values were negatively correlated with lung function (r=-0.275 for the percentage predicted diffusing capacity of the lung for carbon monoxide). Expected survey scores computed from distress values could distinguish disease progression (n=8.8, p=0.004) and death (n=10.2, p=0.002) from no disease progression (n=6.9). Actual survey scores predicted disease progression and death with an area under the curve of 0.60 and 0.64, respectively. Each point increment in actual score increased risk of 12-month mortality by 10%; almost 43% of people scoring above 18 did not survive beyond 105 days.We define a short questionnaire that can score disease distress and predict prognosis, thus assisting clinical decision-making in progressive fibrosis.
引用
- Stewart I, McKeever T, Braybrooke R, et al. Patient-reported distress can aid clinical decision-making in idiopathic pulmonary fibrosis: analysis of the PROFILE cohort. Eur Respir J. 2019. PMID: 30846471. doi:10.1183/13993003.01925-2018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。